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Cardiometabolic disease risk begins in early life and tracks through
the life course. As described in “Sex-speciﬁc trajectories of mea-
sures of cardiovascular health during childhood and adolescence: a
prospective cohort study” (O’Keeffe et al., 2018), we modelled sex-
speciﬁc change in 11 key measures of cardiovascular health from
birth/early childhood to age 18 years in a British birth cohort study,
the Avon Longitudinal Study of Parents and Children (ALSPAC). In
this article, we describe the data used in these analyses. Risk fac-
tors measured included BMI, fat and lean mass, blood pressure and
blood-based biomarkers. Data are from several sources including
cord blood at birth, clinic assessments, routine health records,
questionnaires and nuclear magnetic resonance spectroscopy.
Outcomes were measured over varying time spans from birth or
mid-childhood to age 18 and with different numbers of repeatedvier Inc. This is an open access article under the CC BY license
.atherosclerosis.2018.09.030
. O’Keeffe).
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L.M. O’Keeffe et al. / Data in Brief 23 (2019) 1036872measures per outcome. Analyses were performed using fractional
polynomial and linear spline multilevel models. Further informa-
tion can be found in O’Keeffe et al. (2018).
& 2019 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations tableubject area Epidemiology.
ore speciﬁc subject area Life course epidemiology.
ype of data Tables and ﬁgures of analyzed data.
ow data was acquired Cord blood at birth, clinic assessments, routine health records, ques-
tionnaires and nuclear magnetic resonance (NMR) spectroscopy.
ata format Analyzed
xperimental factors Measures of cardiovascular health from birth or mid-childhood to 18
years in a UK prospective birth cohort study.
xperimental features Participants were recruited at birth and followed up repeatedly over a
period of 18 years.
ata source location Bristol, UK.
ata accessibility Data are with this article.
elated research article O'Keeffe LM et al. Sex-speciﬁc trajectories of measures of cardiovas-
cular health during childhood and adolescence: a prospective cohort
study. Atherosclerosis. 2018; 278 (2018): 190–196.Value of the data
 Repeated measures of 11 key measures of cardiovascular health have been analyzed and trajec-
tories of these are available for use as exposures or outcomes to address other research questions.
 These trajectories may also be useful in comparative work with other cohorts to better understand
change in measures of cardiovascular health during childhood and adolescence, their determinants
and associations with outcomes in later life.
 Modelling strategies used for these data may also be useful for others who wish to examine change
over time in risk factors, where multiple repeat measures are available.1. Data
The data shared here are tables and ﬁgures of analyzed data from the Avon Longitudinal Study of
Parents and Children (ALSPAC). The ALSPAC is a prospective birth cohort study in Southwest England
and is described elsewhere in detail [1–3]. In summary, pregnant women resident in Avon, UK with
expected dates of delivery 1st April 1991 to 31st December 1992 were invited to take part in the
study. Of the 14,541 initial pregnancies, there was a total of 14,676 foetuses, resulting in 14,062 live
births and 13,988 children who were alive at 1 year of age. Ethical approval for the study was
obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Data
was available for 11 measures of cardiovascular health from birth or mid-childhood to 18 years. Data
on the number, timing and sources of measures are detailed elsewhere [1–7]. A comprehensive
proﬁling of offspring circulating lipids, lipoproteins, and metabolites was done by a high-throughput
nuclear magnetic resonance (NMR) metabolomics platform, providing a snapshot of offspring serum
metabolome [8,9]. Non-fasting glucose at age seven from NMR was included in these analyses. Data
were analyzed by sex from birth to 18 years. Model ﬁt statistics for analyses performed, characteristics
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of cardiovascular health and results from sensitivity analyses are included in this paper.2. Experimental design, materials and methods
2.1. Study population
The ALSPAC has been described elsewhere in detail [1–3]. The study website contains details of all
the data that is available through a fully searchable data dictionary http://www.bristol.ac.uk/alspac/
researchers/our-data/ [4].
2.2. Methods and statistical analysis
Two approaches, linear splines and fractional polynomials multilevel models were used in the
modelling of trajectories of measures of cardiovascular health [1,10–13].
We derived appropriate powers of height adjustment for DXA-determined fat and lean mass
which were age and sex-speciﬁc and included these in multilevel models (Table 1). Observed and
predicted measurements for models are shown in Tables 2–12. We examined the characteristics of
mothers of participants included in the analysis of insulin (outcome measured on the fewest parti-
cipants and with fewest repeated measures) compared with mothers of participants excluded from
our analysis (Table 13). The mean sex-speciﬁc trajectories of measures of cardiovascular health are
shown in Tables 14–17. We also regressed the observed risk factor at the ﬁrst occasion of measure-
ment and last occasion of measurement (18 years) on sex to examine whether sex differences esti-
mated from the multilevel model at these ages were comparable to the observed data (Table 18). We
restricted the sample for each risk factor to those with at least one measure before and one after the
11-year clinic, to examine whether results from the main analysis were driven by participants with
only a single pre- or post-puberty measure (Figs. 1–4). We repeated analyses of BMI restricted to
participants with more than six measures to examine if results were driven by participants with a
greater number of measures (Fig. 5). We also repeated analyses excluding the observations of par-
ticipants at the 15- and 18-year clinics who reported eating in the four hours preceding these clinics
to examine if our results were altered by the inclusion of some non-fasted bloods (Figs. 6 and 7).
Glucose at age 15 and 18 from the NMR platform was compared with glucose from standard clinical
chemistry assays at these ages to examine the comparability of NMR and clinical chemistry measures
(Table 19).Table 1
Age and sex-speciﬁc powers of height included in multilevel models of fat mass and lean mass
Fat mass Lean mass
Females
Overall
Age 9 Height^5.2 Height^2.3
Age 11 Height^4.2 Height^2.6
Age 13 Height^3 Height^2
Age 15 Height^2.4 Height^1.8
Age 18 Height^1.8 Height^1.8
Males
Overall
Age 9 Height^6.6 Height^2.1
Age 11 Height^5.4 Height^2.4
Age 13 Height^2 Height^2.8
Age 15 Height^2.4 Height^2.4
Age 18 Height^1.9 Height^1.8
Table 2
Model details for log BMI trajectories by sex
No of contributing
individuals
Assessment of model ﬁt
Total num-
ber of
observations
Number of
individuals
with
1 measure
Mean
observed BMI,
log BMI in kg/
m2 (SD)
Mean pre-
dicted BMI,
log BMI in kg/
m2 (SD)
Mean difference
(observed – pre-
dicted), log BMI in
kg/m2
95% level of agreement
between observed and
predicted, log BMI in
kg/m2
Females
Overall 56,103 6815
1–3 years 9995 5288 2.82 (0.09) 2.81 (0.07) 0.01 -0.10 to 0.11
3–7 years 12,435 5631 2.77 (0.11) 2.77 (0.08) -0.002 -0.15 to 0.15
7–9 years 7114 4209 2.81 (0.13) 2.82 (0.13) -0.01 -0.08 to 0.06
9–11 years 8170 4184 2.88 (0.16) 2.88 (0.15) -0.001 -0.08 to 0.08
11–13 years 6681 3852 2.96 (0.17) 2.95 (0.16) 0.01 -0.07 to 0.10
13–15 years 6036 3742 3.00 (0.16) 3.00 (0.16) 0.01 -0.11 to 0.12
15–18 years 5672 3474 3.10 (0.17) 3.11 (0.16) -0.01 -0.11 to 0.08
Males
Overall 56,665 7170
1–3 years 10,884 5629 2.84 (0.09) 2.83 (0.07) 0.01 -0.10 to 0.11
3–7 years 13,470 5987 2.78 (0.10) 2.78 (0.07) -0.004 -0.14 to 0.14
7–9 years 7247 4342 2.79 (0.12) 2.80 (0.11) -0.01 -0.08 to 0.06
9–11 years 7986 4120 2.86 (0.15) 2.86 (0.14) 0.003 -0.07 to 0.08
11–13 years 6398 3756 2.93 (0.17) 2.92 (0.15) 0.01 -0.06 to 0.09
13–15 years 5895 3686 2.97 (0.16) 2.97 (0.16) 0.001 -0.11 to 0.11
15–18 years 4785 2991 3.07 (0.16) 3.08 (0.16) -0.01 -0.10 to 0.07
Table 3
Model details for log fat mass trajectories by sex
No of contributing
individuals
Assessment of model ﬁt
Total num-
ber of
observations
Number of
individuals
with
1 measure
Mean
observed
(SD), log fat
mass in kg
Mean pre-
dicted (SD),
log fat mass
in kg
Mean difference
(observed – pre-
dicted), log fat
mass in kg
95% level of agreement
between observed and
predicted, ln log fat mass
in kg
Females
Overall 15,619 4461
9 years 3664 3664 2.14 (0.51) 2.15 (0.48) -0.003 -0.15 to 0.14
9–13 years 7204 4135 2.29 (0.52) 2.29 (0.50) 0.002 -0.17 to 0.17
13–15 years 3085 3056 2.69 (0.44) 2.70 (0.42) -0.01 -0.21 to 0.19
15–18 years 5330 3305 2.92 (0.41) 2.92 (0.38) 0.002 -0.15 to 0.16
Males
Overall 14,524 4341
9 years 3577 3577 1.81 (0.60) 1.82 (0.55) -0.01 -0.21 to 0.19
9–13 years 7005 4055 1.98 (0.62) 1.97 (0.58) 0.01 -0.22 to 0.24
13–15 years 2964 2949 2.20 (0.62) 2.23 (0.58) -0.03 -0.33 to 0.27
15–18 years 4555 2870 2.31 (0.64) 2.31 (0.60) 0.01 -0.22 to 0.23
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Table 4
Model details for lean mass trajectories by sex
No of contributing
individuals
Assessment of model ﬁt
Total num-
ber of
observations
Number of
individuals
with 1 measure
Mean
observed
(SD), kg
Mean pre-
dicted (SD), kg
Mean difference
(observed – pre-
dicted), kg
95% level of agreement
between observed and
predicted, kg
Females
Overall 15,680 4474
9 years 3675 3675 23.66 (3.19) 23.65 (3.03) 0.01 -2.12 to 2.15
9–13 years 7228 4148 26.46 (4.82) 26.49 (4.55) -0.03 -2.16 to 2.10
13–15 years 3097 3068 35.21 (4.04) 35.08 (3.91) 0.13 -2.11 to 2.36
15–18 years 5355 3319 37.52 (4.17) 37.56 (3.86) -0.03 -1.75 to 1.68
Males
Overall 14,540 4344
9 years 3586 3586 25.51 (2.98) 25.55 (2.43) -0.04 -3.02 to 2.94
9–13 years 7010 4057 27.78 (4.31) 27.75 (4.02) 0.03 -2.71 to 2.77
13–15 years 2964 2949 40.90 (7.16) 41.04 (6.28) -0.14 -3.57 to 3.28
15–18 years 4564 2874 52.25 (7.09) 52.20 (6.88) 0.05 -2.18 to 2.28
Table 5
Model details for SBP trajectories by sex
No of contributing
individuals
Assessment of model ﬁt
Total num-
ber of
observations
Number of
individuals
with 1 measure
Mean observed
(SD), mmHg
Mean pre-
dicted (SD),
mmHg
Mean difference
(observed – pre-
dicted), mmHg
95% level of agree-
ment between
observed and pre-
dicted, mmHg
Females
Overall 23,731 4957
7 years 3967 3967 99.06 (9.27) 98.93 (5.49) 0.14 -10.91 to 11.19
7–12 years 14,696 4706 102.96 (9.73) 103.10 (6.30) -0.14 -12.01 to 11.73
12–16 years 6228 3671 114.67 (10.95) 114.17 (7.72) 0.50 -11.16 to 12.17
16–18 years 2807 2702 112.59 (8.53) 112.95 (5.46) -0.36 -12.75 to 12.03
Males
Overall 22,590 4965
7 years 4090 4090 98.83 (9.06) 98.75 (5.33) 0.08 -10.49 to 10.65
7–12 years 14,497 4769 102.35 (9.34) 102.46 (6.06) -0.11 -11.50 to 11.28
12–16 years 5894 3532 116.82 (12.36) 116.42 (9.59) 0.40 -11.42 to 12.21
16–18 years 2199 2139 122.27 (9.42) 122.59 (5.81) -0.32 -12.21 to 11.58
SBP; systolic blood pressure.
Table 6
Model details for DBP trajectories by sex
No of contributing
individuals
Assessment of model ﬁt
Total num-
ber of
observations
Number of
individuals
with 1 measure
Mean
observed
(SD), mmHg
Mean pre-
dicted (SD),
mmHg
Mean difference
(observed – pre-
dicted), mmHg
95% level of agreement
between observed and
predicted, mmHg
Females
Overall 23,731 4957
7 years 3967 3967 56.86 (6.57) 57.07 (3.27) -0.21 -9.04 to 8.63
7–12 years 14,696 4706 58.51 (6.99) 58.10 (3.58) 0.41 -9.81 to 10.64
12–16 years 6228 3671 61.00 (9.23) 61.84 (4.69) -0.84 -12.43 to 10.75
16–18 years 2807 2702 64.87 (5.98) 65.17 (3.43) -0.29 -13.17 to 12.58
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Table 7
Model details for pulse rate trajectories by sex
No of contributing
individuals
Assessment of model ﬁt
Total num-
ber of
observations
Number of
individuals
with 1 measure
Mean
observed
(SD), bpm
Mean pre-
dicted (SD),
bpm
Mean difference
(observed – pre-
dicted), bpm
95% level of agreement
between observed and
predicted, bpm
Females
Overall 23,731 4957
7 years 3967 3967 84.39 (10.69) 84.64 (5.97) -0.25 -13.65 to 13.16
7–12 years 14,696 4706 79.49 (11.37) 79.28 (7.26) 0.21 -13.94 to 14.36
12–16 years 6228 3671 75.99 (11.06) 76.37 (6.34) -0.37 -14.66 to 13.91
16–18 years 2807 2702 67.96 (10.07) 68.24 (5.97) -0.29 -14.98 to 14.41
Males
Overall 22,590 4965
7 years 4090 4090 81.78 (10.59) 81.61 (6.04) 0.18 -12.38 to 12.73
7–12 years 14,497 4769 75.79 (11.49) 75.84 (7.73) -0.05 -13.41 to 13.31
12–16 years 5894 3532 72.00 (11.11) 71.78 (6.74) 0.22 -13.20 to 13.64
16–18 years 2199 2139 63.12 (9.60) 63.37 (5.56) -0.25 -14.55 to 14.05
bpm, beats per minute.
Table 6 (continued )
No of contributing
individuals
Assessment of model ﬁt
Total num-
ber of
observations
Number of
individuals
with 1 measure
Mean
observed
(SD), mmHg
Mean pre-
dicted (SD),
mmHg
Mean difference
(observed – pre-
dicted), mmHg
95% level of agreement
between observed and
predicted, mmHg
Males
Overall 22,589 4965
7 years 4090 4090 56.09 (6.66) 56.32 (3.46) -0.24 -8.87 to 8.40
7–12 years 14,497 4769 57.68 (6.89) 57.27 (3.62) 0.41 -9.45 to 10.27
12–16 years 5894 3532 61.16 (9.91) 62.05 (5.49) -0.89 -12.36 to 10.58
16–18 years 2199 2139 63.47 (6.19) 63.85 (3.66) -0.37 -12.78 to 12.03
DBP; diastolic blood pressure.
Table 8
Model details for glucose trajectories by sex
No of contributing
individuals
Assessment of model ﬁt
Total num-
ber of
observations
Number of
individuals
with 1 measure
Mean
observed,
mmol/l
(SD)
Mean pre-
dicted,
mmol/l
(SD)
Mean difference
(observed – pre-
dicted), mmol/l
95% level of agreement
between observed and
predicted, mmol/l
Females
Overall 6519 3594
7 years 2646 2646 4.14 (0.50) 4.17 (0.24) -0.03 -0.56 to 0.49
7–15 years 3070 2751 4.24 (0.54) 4.23 (0.28) 0.01 -0.56 to 0.58
15–18 years 3449 2347 5.02 (0.37) 5.03 (0.14) -0.01 -0.60 to 0.58
Males
Overall 6533 3661
7 years 2834 2834 4.22 (0.50) 4.26 (0.21) -0.04 -0.63 to 0.56
7–15 years 3290 2941 4.33 (0.55) 4.32 (0.26) 0.01 -0.62 to 0.64
15–18 years 3243 2191 5.22 (0.40) 5.23 (0.13) -0.01 -0.64 to 0.62
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Table 9
Model details for log insulin trajectories by sex
No of contributing
individuals
Assessment of model ﬁt
Total num-
ber of
observations
Number of
individuals
with
1 measure
Mean
observed
(SD), log
insulin in
mu/l
Mean pre-
dicted (SD),
log insulin in
mu/l
Mean difference
(observed – pre-
dicted), log insulin
in mu/l
95% level of agreement
between observed and
predicted, ln log insulin
in mu/l
Females
Overall 901 331
Birth 135 135 1.10 (0.49) 1.10 (0.26) -0.000000001 -0.46 to 0.46
0–9 years 135 135 1.10 (0.49) 1.10 (0.26) -0.000000001 -0.46 to 0.46
9–15 years 271 270 1.66 (0.61) 1.66 (0.43) -0.002 -0.37 to 0.36
15–18 years 495 329 2.17 (0.48) 2.16 (0.27) 0.001 -0.50 to 0.51
Males
Overall 930 331
Birth 127 127 1.03 (0.52) 1.03 (0.16) -0.0000000002 -0.73 to 0.73
9 years 127 127 1.03 (0.52) 1.03 (0.16) -0.0000000002 -0.73 to 0.73
9–15 years 284 283 1.51 (0.61) 1.51 (0.31) -0.001 -0.64 to 0.63
15–18 years 519 330 1.99 (0.55) 1.99 (0.26) 0.0003 -0.75 to 0.75
Table 10
Model details for log triglyceride trajectories by sex
No of contributing
individuals
Assessment of model ﬁt
Total num-
ber of
observations
Number of
individuals
with
1 measure
Mean
observed
(SD), log tri-
glyceride in
mmol/l
Mean pre-
dicted (SD),
log triglycer-
ide in mmol/l
Mean difference
(observed – pre-
dicted), log trigly-
ceride in mmol/l
95% level of agreement
between observed and
predicted, log triglycer-
ide in mmol/l
Females
Overall 10,927 4992
Birth 2358 2358 -0.69 (0.45) -0.69 (0.23) -0.004 -0.45 to 0.44
0–9 years 4915 4055 -0.34 (0.55) -0.35 (0.39) 0.01 -0.50 to 0.52
9–18 years 6012 3333 -0.12 (0.40) -0.11 (0.22) -0.01 -0.53 to 0.52
Males
Overall 10,999 5136
Birth 2412 2412 -0.68 (0.45) -0.68 (0.20) -0.002 -0.49 to 0.49
0–9 years 5157 4294 -0.36 (0.53) -0.37 (0.35) 0.003 -0.54 to 0.55
9–18 years 5842 3276 -0.16 (0.42) -0.16 (0.22) -0.003 -0.56 to 0.55
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Table 11
Model details for non-HDL-c trajectories by sex
No of contributing
individuals
Assessment of model ﬁt
Total num-
ber of
observations
Number of
individuals
with 1 measure
Mean
observed
(SD),
mmol/l
Mean pre-
dicted (SD),
mmol/l
Mean difference
(observed – pre-
dicted), mmol/l
95% level of agreement
between observed and
predicted, mmol/l
Females
Overall 10,891 4979
Birth 2279 2279 1.25 (0.53) 1.28 (0.21) -0.02 -0.65 to 0.60
0–9 years 4856 4031 2.17 (1.05) 2.12 (0.86) 0.06 -0.58 to 0.69
9–18 years 6035 3337 2.74 (0.68) 2.79 (0.52) -0.04 -0.66 to 0.57
Males
Overall 10,983 5119
Birth 2341 2341 1.18 (0.52) 1.20 (0.26) -0.02 -0.53 to 0.49
0–9 years 5096 4264 2.05 (0.98) 2.00 (0.81) 0.05 -0.51 to 0.60
9–18 years 5887 3294 2.55 (0.64) 2.59 (0.52) -0.04 -0.58 to 0.51
HDL-c, high density lipoprotein cholesterol
Table 12
Model details for HDL-c trajectories by sex
No of contributing individuals Assessment of model ﬁt
Total number of
observations
Number of indi-
viduals with
1 measure
Mean observed
(SD), mmol/l
Mean predicted
(SD), mmol/l
Mean difference
(observed – pre-
dicted), mmol/l
95% level of agreement
between observed and
predicted, mmol/l
Females
Overall 10,939 4988
Birth 2320 2320 0.55 (0.24) 0.55 (0.11) -0.00000002 -0.27 to 0.27
0–7 years 2321 2321 0.55 (0.25) 0.55 (0.11) 0.00003 -0.27 to 0.27
7–18 years 8618 3957 1.40 (0.31) 1.40 (0.22) -0.00001 -0.28 to 0.28
Males
Overall 11,019 5127
Birth 2380 2380 0.50 (0.23) 0.50 (0.12) -0.000001 -0.23 to 0.23
0–7 years 2381 2381 0.50 (0.23) 0.50 (0.12) 0.00005 -0.23 to 0.23
7–18 years 8638 4014 1.38 (0.32) 1.38 (0.26) -0.00001 -0.25 to 0.25
HDL-c, high density lipoprotein cholesterol
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Table 13
Characteristics at birth of the mothers of children included in models of insulin (risk factor with least individuals and number
of repeated measures)
Participants included
n¼ 662a
Participants
excluded n¼19,388b
P value for
comparison c
n (%) n (%)
Sex of child
Male 331(50.0) 9746(51.8) 0.355
Female 331(50.0) 9059(48.2)
Maternal marital status
Never married 74(11.4) 2525(19.6) o0.001
Widowed o0.8d(o5d) 18(0.1)
Divorced 19(2.9) 560(4.3)
Separated 9(1.4) 210(1.6)
1st Marriage 512(78.6) 8752(67.8)
Marriage 2 or 3 37(5.7) 848(6.6)
Household social class
Professional 115(18.6) 1426(13.0) o0.001
Managerial & Technical 287(46.5) 4552(41.5)
Non-Manual 141(22.9) 2807(25.6)
Manual 51(8.3) 1513(13.8)
Part Skilled & Unskilled 23(3.7) 670(6.1)
Maternal education
Less than O level 101(15.5) 3655(30.8) o0.001
O level 224(34.4) 4105(34.6)
A level 199(30.6) 2605(22.0)
Degree or above 127(19.5) 1483(12.5)
Partners highest educational qualiﬁcation
Less than O level 138(21.7) 4016(35.3) o0.001
O level 140(22.0) 2416(21.2)
A level 193(30.3) 2930(25.7)
Degree or Above 166(26.1) 2018(17.7)
Maternal smoking during pregnancy
Yes 557(85.3) 9440(74.3) o0.001
No 96(14.7) 3271(25.7)
Mean (SD) Mean (SD) P value
Child gestational age at birth 40(1.55) 38(5.62) o0.001
a Denominators for included participants in this table may be less than N included in full multilevel model due to missing
data for these characteristics at baseline which were not required for our model (age, sex and at least one measure of risk factor
before and after age 11 years were required for inclusion). b Denominator for participants excluded may also vary due to
missing data on the characteristics included in the table.
c P value is for the difference in proportions for categorical variables from χ2 test or difference in means for continuous
variables from t tests between included and excluded participants. d May include zero.
Table 14
Mean sex-speciﬁc trajectories of anthropometric risk factors estimated from multilevel models
Mean trajectory
(95% CI) in females
Mean trajectory
(95% CI) in males
Mean difference in trajec-
tory (95% CI) comparing
females with males
P value for dif-
ference between
females and
males
Log BMI a
Age 1 yr (log BMI, kg/m2) 2.90 (2.89,2.90) 2.89 (2.89,2.90) 0.59% (-0.06,1.23)b 0.077
Age 3 yr (log BMI, kg/m2) 2.75 (2.75,2.75) 2.77 (2.77,2.77) -1.86% (-2.22, -1.49)b o0.001
Age 7 yr (log BMI, kg/m2) 2.80 (2.80,2.80) 2.79 (2.79,2.79) 0.88% (0.46,1.31)b o0.001
Age 9 yr (log BMI, kg/m2) 2.85 (2.85,2.85) 2.83 (2.83,2.83) 2.12% (1.61,2.65)b o0.001
Age 11 yr (log BMI, kg/m2) 2.91 (2.91,2.91) 2.88 (2.88,2.88) 2.98% (2.38,3.58)b o0.001
Age 13 yr (log BMI, kg/m2) 2.98 (2.97,2.98) 2.95 (2.94,2.95) 3.34% (2.69,3.98)b o0.001
Age 15 yr v kg/m2) 3.06 (3.05,3.06) 3.02 (3.02,3.03) 3.14% (2.47,3.82)b o0.001
Age 18 yr (log BMI, kg/m2) 3.14 (3.13,3.14) 3.11 (3.11,3.12) 2.35% (1.62,3.09b o0.001
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Table 14 (continued )
Mean trajectory
(95% CI) in females
Mean trajectory
(95% CI) in males
Mean difference in trajec-
tory (95% CI) comparing
females with males
P value for dif-
ference between
females and
males
Log height -adjusted fat
mass
Age 9 yr (log fat mass, kg) 2.01 (1.99,2.03) 1.77 (1.74,1.79) 27.3% (22.94,31.82)b o0.001
Change 9–13 yr (log fat mass,
kg/yr)
0.16 (0.15,0.16) 0.13 (0.12,0.14) 3.02%/yr (1.93,4.12)b o0.001
Change 13–15 yr (log fat
mass, kg/yr)
0.10 (0.09,0.11) -0.06 (-0.07, -0.05) 17.85%/yr (16.56,19.16)b o0.001
Change 15–18 yr (log fat
mass, kg/yr)
0.06 (0.05,0.06) 0.10 (0.09,0.10) -3.71%/yr (-4.44, -2.98)b o0.001
Age 18 yr (log fat mass, kg) 3.01 (3.00,3.03) 2.44 (2.42,2.46) 77.8% (72.98,82.77)b o0.001
Height-adjusted lean mass
Age 9 yr (kg) 20.78 (20.69,20.88) 23.97 (23.86,24.09) -3.19 kg (-3.34, -3.04) o0.001
Change 9–13 yr (kg/yr) 3.25 (3.22,3.28) 2.32 (2.26,2.38) 0.93 kg/yr (0.86,1.00) o0.001
Change 13–15 yr (kg/yr) 1.52 (1.44,1.61) 7.62 (7.53,7.70) -6.09 kg/yr (-6.21, -5.97) o0.001
Change 15–18 yr (kg/yr) 0.41 (0.37,0.44) 2.51 (2.44,2.59) -2.11 kg/yr (-2.19, -2.02) o0.001
Age 18 yr (kg) 37.64 (37.50,37.77) 56.03 (55.80,56.26) -18.39 kg (-18.66, -18.12) o0.001
a BMI is modelled using fractional polynomials. For ease of interpretation, the predicted log BMI for females and males is
shown at each age rather than the coefﬁcients for the fractional polynomial terms from the model.
b The difference between females and males for BMI and fat mass is back transformed from the log scale for ease of
interpretation and is interpreted as the percentage difference in the mean level comparing females with males or percentage
difference in change per year comparing females with males.
Table 15
Mean sex-speciﬁc trajectories of blood pressure and pulse rate estimated from multilevel models
Mean trajectory
(95% CI) in females
Mean trajectory (95%
CI) in males
Mean difference in trajec-
tory (95% CI) comparing
females with males
P value for differ-
ence between
females and males
SBP
Age 7 yr (mmHg) 98.14 (97.84,98.43) 98.00 (97.72,98.28) 0.14 (-0.27,0.55) 0.497
Change 7–12 yr
(mmHg/yr)
1.85 (1.78,1.92) 1.64 (1.57,1.70) 0.22 (0.12,0.32) o0.001
Change 12–16 yr
(mmHg/yr)
3.82 (3.70,3.94) 5.78 (5.66,5.90) -1.97 (-2.13,-1.80) o0.001
Change 16–18 yr
(mmHg/yr)
-5.74 (-6.00,-5.49) -3.82 (-4.09,-3.54) -1.93 (-2.30,-1.56) o0.001
Age 18 yr (mmHg) 111.18 (110.86,111.51) 121.67 (121.27,122.07) -10.48 (-11.00,-9.97) o0.001
DBP
Age 7 yr (mmHg) 57.13 (56.92,57.34) 56.34 (56.13,56.54) 0.79 (0.50,1.09) o0.001
Change 7–12 yr
(mmHg/yr)
0.09 (0.03,0.14) 0.14 (0.08,0.19) -0.05 (-0.12,0.03) 0.247
Change 12–16 yr
(mmHg/yr)
2.34 (2.24,2.44) 2.81 (2.70,2.92) -0.47 (-0.62,-0.32) o0.001
Change 16–18 yr
(mmHg/yr)
-1.01 (-1.21,-0.80) -2.49 (-2.73,-2.25) 1.49 (1.17,1.81) o0.001
Age 18 yr (mmHg) 64.91 (64.67,65.16) 63.26 (62.98,63.55) 1.65 (1.27,2.02) o0.001
Pulse rate
Age 7 yr (bpm) 85.77 (85.43,86.11) 82.71 (82.38,83.04) 3.06 (2.58,3.54) o0.001
Change 7–12 yr
(bpm/yr)
-1.77 (-1.86,-1.69) -1.89 (-1.97,-1.81) 0.11 (0.00,0.23) 0.053
Change 12–16 yr
(bpm/yr)
-0.17 (-0.30,-0.05) -0.76 (-0.89,-0.63) 0.59 (0.41,0.77) o0.001
Change 16–18 yr
(bpm/yr)
-4.73 (-5.00,-4.46) -4.08 (-4.36,-3.79) -0.65 (-1.04,-0.27) o0.001
Age 18 yr (bpm) 66.75 (66.37,67.13) 62.07 (61.66,62.48) 4.68 (4.12,5.24) o0.001
bpm, beats per minute; DBP, diastolic blood pressure; SBP, systolic blood pressure.
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Table 16
Mean sex-speciﬁc trajectories of glucose and log insulin estimated from multilevel models
Mean trajectory
(95% CI) in females
Mean trajectory
(95% CI) in males
Mean difference in
trajectory (95% CI) compar-
ing females with males
P value for dif-
ference between
females and
males
Glucose
Age 7 yr (mmol/l) 4.11 (4.09,4.13) 4.18 (4.16,4.20) -0.08mmol/l (-0.10,-0.05) o0.001
Change 7–15 yr (mmol/l/yr) 0.13 (0.13,0.14) 0.15 (0.14,0.15) -0.01mmol/l/yr (-0.02,-0.01) o0.001
Change 15–18 yr (mmol/l/yr) -0.09 (-0.10,-0.08) -0.08 (-0.09,-
0.07)
-0.02mmol/l/yr (-0.03, 0.00) 0.023
Age 18 yr (mmol/l) 4.90 (4.88,4.92) 5.12 (5.10,5.14) -0.22mmol/l (-0.25, -0.19) o0.001
Log insulin
Birth (log insulin, mu/l) 1.10 (1.01,1.18) 1.02 (0.93,1.11) 7.81% (-4.46,21.65)a 0.223
Change 0–9 yr
(log insulin, mu/l /yr)
0.05 (0.04,0.06) 0.04 (0.03,0.06) 0.67%/yr (-1.19,2.56)a 0.486
Change 9–15 yr
(log insulin, mu/l /yr)
0.14 (0.12,0.15) 0.14 (0.12,0.15) 0.11%/yr (-2.24,2.52)a 0.928
Change 15–18 yr
(log insulin, mu/l /yr)
-0.13 (-0.16, -0.09) -0.15 (-0.18, -0.11) 2.17%/yr (-2.52,7.08)a 0.371
Age 18 yr (log insulin, mu/l) 1.97 (1.91,2.05) 1.77 (1.69,1.84) 22.85% (10.76,36.35)a 0.000
a The difference between females and males is back transformed from the log scale for ease of interpretation and is
interpreted as the percentage difference in the mean level comparing females with males or percentage difference in change
per year comparing females with males.
Table 17
Mean sex-speciﬁc trajectories of log triglyceride and cholesterol estimated from multilevel models
Mean trajectory
(95% CI) in females
Mean trajectory
(95% CI) in males
Mean difference in trajec-
tory (95% CI) comparing
females with males
P value for
difference
between
females and
males
Log triglyceride
Birth (log triglyceride, mmol/l) -0.69 (-0.70,-0.67) -0.68 (-0.70,-0.66) -0.70% (-3.17,1.84)a 0.586
Change 0–9 yr
(log triglyceride, mmol/l/yr)
0.09 (0.08,0.09) 0.08 (0.08,0.08) 0.90%/yr (0.53,1.28)a o0.001
Change 9–18 yr
(log triglyceride, mmol/l/yr)
-0.04 (-0.05,-0.04) -0.04 (-0.04,-0.04) -0.41%/yr (-0.72,-0.09)a 0.012
Age 18 yr
(log triglyceride, mmol/l)
-0.29 (-0.31,-0.28) -0.33 (-0.35,-0.31) 3.80% (1.59,6.06)a 0.001
HDL-c
Birth (mmol/l) 0.55 (0.54,0.56) 0.50 (0.49,0.51) 0.05mmol/l (0.03,0.06) o0.001
Change 0–7 yr (mmol/l/yr) 0.13 (0.13,0.13) 0.15 (0.15,0.15) -0.02mmol/l/yr (-0.02,-0.02) o0.001
Change 7–18 yr (mmol/l/yr) -0.01 (-0.01,-0.01) -0.04 (-0.04,-0.03) 0.02mmol/l/yr (0.02,0.02) o0.001
Age 18 yr (mmol/l) 1.32 (1.31,1.33) 1.15 (1.14,1.16) 0.17mmol/l (0.15,0.18) o0.001
Non-HDL-c
Birth (mmol/l) 1.28 (1.26,1.30) 1.22 (1.19,1.24) 0.07mmol/l (0.04,0.10) o0.001
Change 0–9 yr (mmol/l/yr) 0.21 (0.21,0.21) 0.19 (0.19,0.20) 0.02mmol/l/yr (0.01,0.02) o0.001
Change 9–18 yr (mmol/l/yr) -0.07 (-0.08,-0.07) -0.07 (-0.08,-0.07) 0.00mmol/l/yr (-0.01,0.00) 0.265
Age 18 yr (mmol/l) 2.49 (2.46,2.52) 2.30 (2.27,2.32) 0.19mmol/l (0.16,0.23) o0.001
HDL-c, high density lipoprotein cholesterol
a The difference between females and males is back transformed from the log scale for ease of interpretation and is
interpreted as the percentage difference in the mean level comparing females with males or percentage difference in change
per year comparing females with males.
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Tablee 18
Sex differences in risk factors at ﬁrst and last available measure from linear regressions compared to differences predicted from
multilevel models
N participants in
regression of risk factor on
sex at each age
Difference in females
compared with males from
regression (95% CI)
Difference in females
compared with males from mul-
tilevel model (95% CI)
Log BMI (kg/m2)a
Age 1 1060 -1.64(-2.60,-0.68) 0.59 (-0.05,1.24)
Age 18 995 2.31(0.03,4.59) 2.35 (1.62,3.09)
Log fat mass (kg)a
Age 9 7241 39.53(35.98,43.08) 27.30 (22.94,31.82)
Age 18 4804 75.42(70.21,80.63) 77.80 (72.98,82.77)
Lean mass (kg)
Age 9 7261 -1.85(-1.99,-1.71) -3.19 (-3.34,-3.04)
Age 18 4819 -17.14(-17.44,-16.84) -18.39 (-18.66,-18.12)
SBP (mmHg)
Age 7 8057 0.23(-0.17,0.63) 0.14 (-0.27,0.55)
Age 18 4629 -10.17(-10.66,-9.68) -10.48 (-11.00,-9.97)
DBP (mmHg)
Age 7 8057 0.77(0.48,1.06) 0.79 (0.50,1.09)
Age 18 4629 1.55(1.22,1.88) 1.65 (1.27,2.02)
Pulse rate (bpm)
Age 7 8057 2.61(2.14,3.07) 3.06 (2.58,3.54)
Age 18 4629 4.53(3.99,5.07) 4.68 (4.12,5.24)
Glucose (mmol/l)
Age 7 5480 -0.08(-0.11,-0.05) -0.08 (-0.10,-0.05)
Age 18 3266 -0.23(-0.26,-0.21) -0.22 (-0.25,-0.19)
Log insulin (mu/l)a
Birth 262 7.80(-5.37,20.97) 7.81 (-4.46,21.65)
Age 18 498 21.06(9.94,32.18) 22.85 (10.76,36.25)
Log triglyceride
(mmol/l)a
Birth 4770 -1.00(-3.53,1.53) -0.70 (-3.17,1.84)
Age 18 3254 2.11(-0.41,4.63) 3.80 (1.59,6.06)
HDL-c (mmol/l)
Birth 4700 0.05(0.03,0.06) 0.05 (0.03,0.06)
Age 18 3277 0.16(0.14,0.18) 0.17 (0.15,0.18)
Non-HDL-c (mmol/l)
Birth 4620 0.07(0.04,0.10) 0.07 (0.04,0.10)
Age 18 3275 0.20(0.16,0.25) 0.19 (0.16,0.23)
bpm, beats per minute; DBP, diastolic blood pressure; HDL-c, high density lipoprotein; SBP, systolic blood pressure.
a Risk factor is log transformed. The difference between females and males for the risk factor is back transformed from the
log scale for ease of interpretation and is interpreted as the percentage difference in the mean level comparing females with
males at the age shown.
N=8,510 N=6,502 N=6,517
Fig. 1. Mean predicted sex-speciﬁc trajectories of BMI (1 to 18 years), height-adjusted fat mass and height-adjusted lean mass
(9 to 18 years) among participants with at least one measure before and after 11 years.
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N=7,264 N=7,264 N=7,264 
Shaded areas represent 95% confidence intervals. Note the different age range on the X axis for each outcome. DBP, diastolic blood pressure; SBP, systolic blood 
pressure. 
Fig. 2. Mean predicted sex-speciﬁc trajectories of SBP, DBP and pulse from 7 to 18 years among participants with at least one
measure before and after 11 years.
N=2,979 
Shaded areas represent 95% confidence intervals. 
Note the different age range on the X axis for each outcome 
Fig. 3. Mean predicted sex-speciﬁc trajectories of glucose from 7 to 18 years among participants with at least one measure
before and after 11 years.
N=3,969      N=3,990                    N=3,982   
Shaded areas represent 95% confidence intervals. Note the different age range on the X axis for each outcome. HDL-c, high density lipoprotein cholesterol 
Fig. 4. Mean predicted sex-speciﬁc trajectories of triglyceride, HDL-c and non-HDL-c from birth to 18 years among participants
with at least one measure before and after 11 years.
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N=8,247 
Shaded areas represent 95% confidence intervals. 
Note the different age range on the X axis for each outcome 
Fig. 5. Mean predicted sex-speciﬁc trajectory of BMI from 1 to 18 years among participants with 6 or more measures.
N=7,159  N=662
Shaded areas represent 95% confidence intervals. Note the different age range on the X axis for each outcome 
Fig. 6. Mean predicted sex-speciﬁc trajectories of glucose (7 - 18 years) and insulin (birth - 18 years) excluding participants
who reported eating before either the 15- or 18-year clinic.
N=10,074 N=10,060 N=10,043
Shaded areas represent 95% confidence intervals. Note the different age range on the X axis for each outcome. HDL-c, high density lipoprotein cholesterol 
Fig. 7. Mean predicted sex-speciﬁc trajectories of triglyceride, HDL-c and non-HDL-c from birth to 18 years excluding parti-
cipants who reported eating before either the 15- or 18-year clinic.
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Table 19
Sex differences in glucose from main ALSPAC clinic compared with sex difference in glucose from NMR spectroscopy at 15- and
18-year clinic with females as reference group.
N participants in
regression of risk
factor on sex at
each age
Difference in
females compared
with males from
main clinic (95%
CI)
Difference in females
compared with males
from NMR spectro-
scopy (95% CI)
Age 15 3464 -0.16 (-0.19, -0.14) -0.14 (-0.16, -0.11)
Age 18 3266 -0.23 (-0.26, -0.21) -0.17 (-0.20, -0.15)
NMR, Nuclear Magnetic Resonance.
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